Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FUWTP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,838
Award facts
- Contract value 100% obligated
- $6,837.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,837.84 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen auto-injectors, with an ultimate completion date of October 27, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation was issued on October 24, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly prescribed for moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis, indicating this order supports pharmaceutical supply needs within the federal healthcare system, particularly for military medical programs.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for the Defense Health Agency and other federal healthcare systems, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical supplies through the DLA's global pharmaceutical support vehicle. The company's position as a prime vendor reflects its capability to meet federal procurement requirements across multiple therapeutic domains supporting military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB26FUWTP?
SPE2DB26FUWTP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FUWTP worth?
The government has obligated $6,838 on SPE2DB26FUWTP.
Is contract SPE2DB26FUWTP an order under another contract?
Yes. SPE2DB26FUWTP is a delivery order under SPE2DB25D3018, an indefinite delivery contract.
Was contract SPE2DB26FUWTP competed?
The extent of competition for SPE2DB26FUWTP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award